drugset / Trial / NCT00600691

The Use of Finasteride to Reduce Hematuria and Hematospermia Following TRUS Prostate Biopsy

NCT00600691

RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of our study is primarily to evaluate the effects of 5mg finasteride on hematuria and hematospermia commonly associated with prostate biopsies. We hypothesize that 5mg of finasteride daily for two weeks preceding TRUS prostate biopsy and one week following will reduce hematuria and hematospermia commonly seen as complications following prostate biopsy. We also hypothesize that reducing complications will decrease concern among subjects and make for a more tolerable overall procedure than compared with subjects treated with placebo.

Timeline

Start
2008-03
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Finasteride Small molecule 5 mg Oral